FindMyKOL

Jeffrey Rosenfeld, MD

Enriched profile

Professor of Neurology and Associate Chairman of Department of Neurology, Loma Linda University School of Medicine · Loma Linda University School of Medicine

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Fresno, CA · West · United StatesSpecialtyNeuromuscular Medicine
Active KOLEmergingFindMyKOL type: EliteLatest publicationNone indexedOnline presenceNone verifiedPayments2021–2025NIH fundingNone on fileWhy? →

Jeffrey Rosenfeld is Professor of Neurology and Associate Chairman of Department of Neurology, Loma Linda University School of Medicine at Loma Linda University School of Medicine. ClinicalTrials.gov lists 4 registered studies with this person as an investigator.

Data verified 4 Nov 2026

Overview

Updated 4 Nov 2026

Jeffrey Rosenfeld, MD, is Professor of Neurology and Associate Chairman of Department of Neurology, Loma Linda University School of Medicine. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 17 companies.

  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 17 companies

Generated from the cited public record · current as of 4 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
ALS4 trialsMotor Neuron Disease3 trialsMuscular Atrophy1 trialMuscular Atrophy, Spinal1 trialAtrophy1 trialParalysis1 trialBulbo-Spinal Atrophy, X-Linked1 trialBulbar Palsy, Progressive1 trialAlzheimer's / DementiaMyasthenia GravisMigraine / HeadacheCIDP / Inflammatory NeuropathyMultiple Sclerosis

Drugs & molecules

across trials, industry payments and publications
Solirisgeneric · EculizumabClinical trials—Industry payments1Publications3Vyvgartgeneric · Efgartigimod alfaClinical trials—Industry payments118Publications—Vyvgart Hytrulogeneric · Efgartigimod alfa / hyaluronidaseClinical trials—Industry payments50Publications—Relyvriogeneric · Phenylbutyrate / taurursodiolClinical trials—Industry payments31Publications—Radicavageneric · EdaravoneClinical trials—Industry payments21Publications—Firdapsegeneric · AmifampridineClinical trials—Industry payments11Publications—EvrysdiClinical trials—Industry payments10Publications—Spinrazageneric · NusinersenClinical trials—Industry payments6Publications—Exservangeneric · RiluzoleClinical trials—Industry payments4Publications—Ultomirisgeneric · RavulizumabClinical trials—Industry payments4Publications—Rystiggogeneric · RozanolixizumabClinical trials—Industry payments3Publications—AGAMREEClinical trials—Industry payments2Publications—

Works with

trial sponsors and companies reporting payments
Argenx Us, Inc.Clinical trials—Industry payments170Amylyx Pharmaceuticals, Inc.Clinical trials—Industry payments31Mitsubishi Tanabe Pharma America, Inc.Clinical trials—Industry payments28Catalyst Pharmaceuticals, Inc.Clinical trials—Industry payments13UCB, Inc.Clinical trials—Industry payments13Alexion Pharmaceuticals, Inc.Clinical trials—Industry payments10Genentech USA, Inc.Clinical trials—Industry payments9Biogen, Inc.Clinical trials—Industry payments8Amgen Inc.Clinical trials—Industry payments2Baxter HealthcareClinical trials—Industry payments2Saol Therapeutics Inc.Clinical trials—Industry payments2CSL BehringClinical trials—Industry payments1Genentech, Inc.Clinical trials—Industry payments1Grifols USA, LLCClinical trials—Industry payments1Loma Linda UniversityClinical trials1Industry payments—Massachusetts General HospitalClinical trials1Industry payments—National Center for Complementary and Integrative Health (NCCIH)Clinical trials1Industry payments—Tanabe Pharma America, Inc.Clinical trials—Industry payments1The Avicena GroupClinical trials1Industry payments—Travere Therapeutics, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓

Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
17companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

An office address from a public listing. This research profile has no federal registry record to draw from.

Office address

11370 Anderson Street, #B100, Loma Linda, CA 92354

From the cited public source.Collected 4 Nov 2026.View source ↗

Clinical trials

Updated 4 Nov 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

All 4 trial records: search, sort and filter.Explore →

Industry payments

Updated 4 Nov 2026

17 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 36 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 4 Nov 2026

3 congress contributions (2024–2026) across AAN per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria
    Article905 citations2017
    doi.org ↗
  2. 02
    Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
    Article845 citations2017
    doi.org ↗
  3. 03
    Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review)[RETIRED]
    Article807 citations2009
    doi.org ↗
  4. 04
    Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review)
    Article674 citations2009
    doi.org ↗
  5. 05
    Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial
    Article241 citations2014
    doi.org ↗
All 25 cited works: search, sort and filter.Explore →

Network

Updated 4 Nov 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Carlayne E. Jackson14Jonathan Katz14Jeremy M. Shefner12Andrea Swenson11Merit Cudkowicz10Namita Goyal10Tahseen Mozaffar10Michael G Benatar9Mazen M. Dimachkie9Mamatha Pasnoor9Said R. Beydoun9James D. Berry8Michael D. Weiss8Robert M. Pascuzzi8John T. Kissel8Richard J. Barohn8Tuan Vu7Lindsay A. Zilliox7Ratna K. Bhavaraju-Sanka7Jeffrey M. Statland7Ludwig Gutmann7Jaimin Shah7Stanley H. Appel6Kourosh Rezania6James F. Howard6Edward J. Kasarskis6Jinsy A. Andrews6Michael Joseph Strong6Richard Bedlack6Christopher S. Nance6Ericka P. Simpson6April McVey6Terry D Heiman-Patterson5Cynthia L. Bodkin5Sharon Nations5Miriam L. Freimer5Brian Minton5Vinay Chaudhry5James B. Caress5Robert P. Bowser5

Online presence

Updated 4 Nov 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    als.org/support/certified-centers-clinics/loma-linda-university-als-mnd-program-center-restorative

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →als.org ↗
  • Other

    experts.llu.edu/en/persons/jeffrey-rosenfeld

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →experts.llu.edu ↗
  • Other

    murrieta.lluh.org/provider/rosenfeld-jeffrey

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →murrieta.lluh.org ↗
  • X / Twitter

    neurosense-tx.com/team-1/prof-jeffery-rosenfeld

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurosense-tx.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 4 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurosense-tx.com ↗
  • PhD
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurosense-tx.com ↗
  • FAAN (Fellow of the American Academy of Neurology)
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →als.org ↗

Editorial & leadership roles

journal and society appointments

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.